Literature DB >> 11420713

Chromatin remodeling: why it is important in cancer.

A P Wolffe1.   

Abstract

A typical human cell expresses only a few thousand of the more than 30 000 genes contained within our chromosomes. The chromosomal infrastructure is essential for gene control, determining both active and repressed states. It is important not only to turn the right genes on but also to turn the right genes off. Histones and chromatin components have key roles in this decision making process. Mistakes have severe consequences. If as few as three inappropriate genes are turned off, a normal cell can be converted into a cancer cell. This epigenetic silencing of genes underlies a new approach to cancer therapy. Advances in the biochemistry and genetics of chromatin remodeling reveal that gene inactivation depends on the recruitment of enzymes that control the display of DNA within the chromosome. Mistargeting of these enzymes leads to tumorigenesis, but inhibition of their activity presents a novel approach to therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420713     DOI: 10.1038/sj.onc.1204322

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability.

Authors:  Jim Jinn-Chyuan Sheu; Bin Guan; Jung-Hye Choi; Athena Lin; Chia-Huei Lee; Yi-Ting Hsiao; Tian-Li Wang; Fuu-Jen Tsai; Ie-Ming Shih
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.

Authors:  Fu-Min Fang; Chien-Feng Li; Hsuan-Ying Huang; Ming-Tsong Lai; Chih-Mei Chen; I-Wen Chiu; Tian-Li Wang; Fuu-Jen Tsai; Ie-Ming Shih; Jim Jinn-Chyuan Sheu
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  Protein-protein Förster resonance energy transfer analysis of nucleosome core particles containing H2A and H2A.Z.

Authors:  Duane A Hoch; Jessica J Stratton; Lisa M Gloss
Journal:  J Mol Biol       Date:  2007-06-02       Impact factor: 5.469

4.  Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.

Authors:  Huaying Liu; Xiaoling Li; Zhaoxia Niu; Liming Zhang; Ming Zhou; He Huang; Jiajin He; Wenling Zhang; Lan Xiao; Yunlian Tang; Li Wang; Guiyuan Li
Journal:  J Histochem Cytochem       Date:  2007-12-10       Impact factor: 2.479

5.  Identification of a small molecule inhibitor of Sir2p.

Authors:  A Bedalov; T Gatbonton; W P Irvine; D E Gottschling; J A Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

6.  Rsf-1 overexpression in human prostate cancer, implication as a prognostic marker.

Authors:  Hui Li; Yi Zhang; Yue Zhang; Xue Bai; Yang Peng; Ping He
Journal:  Tumour Biol       Date:  2014-03-01

7.  High-level activation of transcription of the yeast U6 snRNA gene in chromatin by the basal RNA polymerase III transcription factor TFIIIC.

Authors:  Sushma Shivaswamy; George A Kassavetis; Purnima Bhargava
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 8.  Epigenetic Determinants of Cancer.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

9.  Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.

Authors:  Huaying Liu; Ming Zhou; Xiaomin Luo; Liming Zhang; Zhaoxia Niu; Cong Peng; Jian Ma; Shuping Peng; Houde Zhou; Bo Xiang; Xiayu Li; Shufang Li; Jiajin He; Xiaoling Li; Guiyuan Li
Journal:  BMC Mol Biol       Date:  2008-12-27       Impact factor: 2.946

10.  Monitoring the effect of belinostat in solid tumors by H4 acetylation.

Authors:  Lena Marquard; Kamille Dumong Petersen; Morten Persson; Kirsten Damgaard Hoff; Peter Buhl Jensen; Maxwell Sehested
Journal:  APMIS       Date:  2008-05       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.